BioMarin recently purchased 17% of CPRX and with CPP115 so valuable to BMRN because it is a HUGE pipeline of extremely valuable orphan drugs, BioMarin is moving in for the buyout before shares get too expensive. BMRN could easily pay part in cash and majority in stock. Buyout price will be between $6 and $8 if it happens soon otherwise CPRX shares will continue to climb making it too expensive for BMRN to purchase. Either way, CPRX is very undervalued and headed much higher very soon. Just look at the charts for the past 4 months. Straight up form here. Of course there will always be ups and downs along the way, but the trend is clearly up, and up and up!